Myasthenia Gravis June is Myasthenia Gravis Awareness Month. Myasthenia gravis is a disorder causing weakness and easy fatigue of voluntary muscles. It is caused by a breakdown in the communication...
Irritable Bowel Syndrome (IBS) - Market Insight, Epidemiology and Market Forecast - 2028 Irritable Bowel Syndrome affects 1 in 5 people and usually develops in the age of 20 to 30 years. Click here to get free sample pages: https://www.delveinsight.com/dev-sample.php?form_name=Irritable-Bowel-Syndrome-(IB...
Find MoreGSK to spend USD 100 M to boost its vaccine production Drug maker GlaxoSmithKline has announced to invest USD100 million in its vaccine production site in Montana-one of its nine manufacturing units in the USA. In order to cope with the supply issues GSK faced last year, the company wishes to boost its vaccine p...
Find MoreThe world gears up to celebrate the last week of April as World Immunization Week. This week aims to promote the use of vaccines to protect everyone against several diseases and keep them immunized. PROTECTED TOGETHER: VACCINES WORK!
Find MoreThe concept of sleep as a passive movement of unconsciousness has long been ruled out. But this act of rejuvenation hasn't just been restricted to the phase of resting. Usually, sleepers undergo five stages of sleep consisting of both REM (Rapid Eye Movement) and N-REM (Non- Rapid Eye Movement), each lasting f...
Find MoreStemline gives in-licenses global rights to SL-1001 Stemline Therapeutics, Inc. is a biopharmaceutical company focused on development and commercialization of novel oncology therapeutics, has licensed worldwide rights to a preclinical molecule RET (rearranged during transfection) kinase inhibitor. The RET kinase...
Find MoreGene editing, a possible treatment, for inherited kidney disease Joubert syndrome, an inherited brain disorder that causes kidney failure in patients. This requires a transplant or dialysis. A mutation in the gene CEP290 causes the inherited form of kidney disease and scientists in the U.K. to apprise of having an e...
Find MoreThe pancreatic cancer drug of GlaxoSmithKline moves to phase 1 The experimental drug, GSK095 of GlaxoSmithKline is made to work in order with a checkpoint that are inhibiting medicines in the empowerment of the immune system to introduce a more aggressive attack against tumours than with checkpoint inhibitors alone...
Find MoreNovartis comes up with an answer for breast cancer with PI3K drug alpelisib Novartis comes up with an answer with its recent data on BYL719 (alpelisib) in combination with fulvestrant. Their alpha-specific drug for PIK3CA mutated HR+/HER2- advanced breast cancer, BYL719 plus fulvestrant nearly doubled the progressio...
Find MoreOrchard files for USD173 Million IPO to run pivotal gene therapy trials Orchard Therapeutics, Transatlantic biotech, has filed to raise USD 173 million in an IPO. This will lead it to take three gene therapies through the clinic. Orchard recognised itself as one of the broadest clinical-phase gene therapy pipelines ...
Find MoreCancer immunotherapy which is known to reactivate weakened immune cells of cancer patients, has yiel.....
Find MoreSoft-tissue sarcoma (STS) is a rare sarcoma that develops in connective tissues such as the muscles,.....
Find MoreDigital health technologies can fill the current gaps in oncology care while rebalancing the existin.....
Find MoreCell therapies now are often recommended to treat cancer in several ways, out of which CAR T-cell th.....
Find MoreToday, Artificial Intelligence has been used effectively in data processing, drug discovery, aiding .....
Find MoreAnorexia is the loss of the desire to eat, whereas cachexia results from the skeletal muscle mass in.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.